The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy

The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy

Chun-Lu Shu,1 Yu-Ling Liu2 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People’s Republic of China; 2Department of Medical Laboratory Science, Fenyang College of Shanxi Medical Univer...

Full description

Bibliographic Details
Main Authors: Shu CL, Liu YL
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Cancer Management and Research
Subjects:
non-small cell lung cancer
kras g12c mutations
targeted therapy
immunotherapy.
Online Access:https://www.dovepress.com/the-path-to-personalized-treatment-in-kras-mutant-non-small-cell-lung--peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/the-path-to-personalized-treatment-in-kras-mutant-non-small-cell-lung--peer-reviewed-fulltext-article-CMAR

Similar Items